Loading...
Recent deposits
-
Tess van Meerhaeghe, Naoka Murakami, Alain Le Moine, Sophie Brouard, Ben Sprangers, et al.. Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients. Clinical Kidney Journal, 2024, 17 (4), pp.sfae061. ⟨10.1093/ckj/sfae061⟩. ⟨inserm-04587083⟩
-
Hoa Le Mai, Nicolas Degauque, Marine Lorent, Marie Rimbert, Karine Renaudin, et al.. Kidney allograft rejection is associated with an imbalance of B cells, regulatory T cells and differentiated CD28-CD8+ T cells: analysis of a cohort of 1095 graft biopsies. Frontiers in Immunology, 2023, 14, ⟨10.3389/fimmu.2023.1151127⟩. ⟨inserm-04192707⟩
-
Sharon Savage, Mathias Viard, Colm O’huigin, Weiyin Zhou, Meredith Yeager, et al.. Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia. American Journal of Human Genetics, 2020, 106 (2), pp.264-271. ⟨10.1016/j.ajhg.2020.01.004⟩. ⟨inserm-02490571⟩
-
Léo Boussamet, Emmanuel Montassier, Camille Mathé, Alexandra Garcia, Jérémy Morille, et al.. Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study. Scientific Reports, 2024, 14 (1), pp.7786. ⟨10.1038/s41598-024-57949-4⟩. ⟨inserm-04587139⟩
-
Stanislas Demuth, Chadia Ed-Driouch, Cédric Dumas, David Laplaud, Gilles Edan, et al.. Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health data. European Journal of Neurology, 2024, pp.e16363. ⟨10.1111/ene.16363⟩. ⟨inserm-04676399⟩
-
Marina Vivarelli, Jonathan Barratt, Laurence Beck, Fadi Fakhouri, Daniel Gale, et al.. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 2024, 106 (3), pp.369-391. ⟨10.1016/j.kint.2024.05.015⟩. ⟨inserm-04676176⟩
Number of full texts
846
Number of references
344
SEARCH